title: Anti-metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer.
abstract: The anti-tumorigenic effects that type 1 interferons (IFN1) elicited in the in vitro studies prompted consideration of IFN1 as a potent candidate for clinical treatment. Though not all patients responded to IFN1, clinical trials have shown that patients with high risk melanoma, a highly refractory solid malignancy, benefit greatly from intermediate IFN1 treatment in regards to relapse-free and distant-metastasis-free survival. The mechanisms by which IFN1 treatment at early stages of disease suppress tumor recurrence or metastatic incidence are not fully understood. Intracellular IFN1 signaling is known to affect cell differentiation, proliferation, and apoptosis. Moreover, recent studies have revealed specific IFN1-regulated genes that may contribute to IFN1-mediated suppression of cancer progression and metastasis. In concert, expression of these different IFN1 stimulated genes may impede numerous mechanisms that mediate metastatic process. Though, IFN1 treatment is still utilized as part of standard care for metastatic melanoma (alone or in combination with other therapies), cancers find the ways to develop insensitivity to IFN1 treatment allowing for unconstrained disease progression. To determine how and when IFN1 treatment would be most efficacious during disease progression, we must understand how IFN1 signaling affects different metastasis steps. Here, we specifically focus on the anti-metastatic role of endogenous IFN1 and parameters that may help to use pharmaceutical IFN1 in the adjuvant treatment to prevent cancer recurrence and metastatic disease.
authors.affiliation: Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: anortiz@vet.upenn.edu.
authors.forename: Angélica
authors.initials: A
authors.lastname: Ortiz
authors.affiliation: Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: syfuchs@vet.upenn.edu.
authors.forename: Serge Y
authors.initials: SY
authors.lastname: Fuchs
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects* / Q000276:immunology; D002454:Cell Differentiation / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D009362:Neoplasm Metastasis; D015398:Signal Transduction / Q000187:drug effects* / Q000276:immunology
chemical_list: D007370:Interferon Type I
keywords: Cancer metastasis; Colonization; Interferon; Invasion
references.citation: J Biol Chem. 2011 Oct 14;286(41):35733-41
references.pmid: 21865166
references.citation: Blood. 2011 Oct 13;118(15):4179-87
references.pmid: 21821707
references.citation: Clin Cancer Res. 2001 May;7(5):1459-65
references.pmid: 11350918
references.citation: Am J Pathol. 2003 Oct;163(4):1437-47
references.pmid: 14507651
references.citation: Int J Biol Sci. 2013 Nov 09;9(10):1057-69
references.pmid: 24250251
references.citation: Cancer Cell. 2005 Aug;8(2):93-5
references.pmid: 16098461
references.citation: Cancer Res. 1990 Oct 1;50(19):6130-8
references.pmid: 1698118
references.citation: Science. 2011 Mar 25;331(6024):1559-64
references.pmid: 21436443
references.citation: Mol Cancer Res. 2007 Jun;5(6):531-42
references.pmid: 17579115
references.citation: Mol Imaging. 2005 Oct-Dec;4(4):415-6
references.pmid: 16285902
references.citation: Ann Surg. 2006 Jul;244(1):113-20
references.pmid: 16794396
references.citation: Int J Cancer. 1984 Sep 15;34(3):421-6
references.pmid: 6480158
references.citation: J Interferon Cytokine Res. 2013 Apr;33(4):211-25
references.pmid: 23570388
references.citation: Cancer Metastasis Rev. 1991 May;10(1):49-59
references.pmid: 1833083
references.citation: Cancer Metastasis Rev. 2006 Sep;25(3):409-16
references.pmid: 16951987
references.citation: Cancer Res. 2010 Jun 1;70(11):4580-9
references.pmid: 20484040
references.citation: Nat Rev Immunol. 2005 May;5(5):375-86
references.pmid: 15864272
references.citation: Br J Cancer. 2013 Apr 30;108(8):1634-40
references.pmid: 23538388
references.citation: Blood. 2011 Oct 6;118(14):4003-6
references.pmid: 21832278
references.citation: Am J Pathol. 1998 Aug;153(2):333-9
references.pmid: 9708792
references.citation: Cancer Gene Ther. 2001 Jul;8(7):497-505
references.pmid: 11498771
references.citation: Neoplasia. 2006 Jul;8(7):578-86
references.pmid: 16867220
references.citation: Clin Exp Metastasis. 1985 Oct-Dec;3(4):295-304
references.pmid: 3841037
references.citation: Exp Cell Res. 2010 Feb 15;316(4):554-67
references.pmid: 20006606
references.citation: Am J Physiol. 1992 Dec;263(6 Pt 1):G864-70
references.pmid: 1362041
references.citation: Nature. 2009 Apr 16;458(7240):904-8
references.pmid: 19212321
references.citation: Vascul Pharmacol. 2010 May-Jun;52(5-6):199-206
references.pmid: 20045081
references.citation: PLoS Pathog. 2011 Jun;7(6):e1002065
references.pmid: 21695243
references.citation: J Biol Chem. 2010 Jan 22;285(4):2318-25
references.pmid: 19948722
references.citation: Genes Cancer. 2012 Feb;3(2):102-16
references.pmid: 23050043
references.citation: J Cell Sci. 1994 Apr;107 ( Pt 4):983-92
references.pmid: 8056851
references.citation: J Immunother. 2011 Apr;34(3):320-6
references.pmid: 21389866
references.citation: Breast Cancer Res Treat. 1996;39(2):235-8
references.pmid: 8872332
references.citation: Biochim Biophys Acta. 2013 Oct;1830(10):4917-27
references.pmid: 23845726
references.citation: Cancer Immunol Res. 2015 Nov;3(11):1207-17
references.pmid: 26198985
references.citation: J Neuroimmunol. 1995 Jul;60(1-2):99-106
references.pmid: 7642754
references.citation: EMBO Mol Med. 2014 Mar;6(3):384-97
references.pmid: 24480543
references.citation: J Cardiovasc Magn Reson. 2013 Sep 13;15:81
references.pmid: 24034144
references.citation: Oncologist. 1997;2(4):254-267
references.pmid: 10388057
references.citation: Neurochem Int. 1997 Apr-May;30(4-5):449-53
references.pmid: 9106260
references.citation: J Biol Chem. 2012 Oct 19;287(43):36593-608
references.pmid: 22927430
references.citation: J Biol Chem. 2011 Jun 24;286(25):22069-76
references.pmid: 21540188
references.citation: Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19226-31
references.pmid: 23129613
references.citation: Mol Cell Biol. 2009 Dec;29(24):6401-12
references.pmid: 19805514
references.citation: J Palliat Med. 2009 Mar;12(3):219-22
references.pmid: 19254194
references.citation: Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
references.pmid: 24556840
references.citation: J Cell Sci. 2008 Mar 15;121(Pt 6):727-35
references.pmid: 18322269
references.citation: Hellenic J Cardiol. 2005 Jan-Feb;46(1):9-15
references.pmid: 15807389
references.citation: Pigment Cell Melanoma Res. 2010 Dec;23(6):838-40
references.pmid: 21644263
references.citation: Genes Cancer. 2010 Jul;1(7):725-34
references.pmid: 21127735
references.citation: J Neuroimmunol. 1996 Dec;71(1-2):215-22
references.pmid: 8982122
references.citation: Clin Cancer Res. 2004 Mar 1;10 (5):1670-7
references.pmid: 15014018
references.citation: Oncogene. 2012 Jan 12;31(2):161-72
references.pmid: 21666722
references.citation: Oncogene. 2013 Sep 5;32(36):4214-21
references.pmid: 23045272
references.citation: J Interferon Cytokine Res. 2011 May;31(5):451-8
references.pmid: 21361792
references.citation: Cancer Res. 2010 Jul 15;70(14):5649-69
references.pmid: 20610625
references.citation: Clin Cancer Res. 2001 Sep;7(9):2840-53
references.pmid: 11555602
references.citation: Int J Cell Biol. 2012;2012:676731
references.pmid: 22505933
references.citation: Eur J Pharmacol. 1999 Apr 9;370(2):145-51
references.pmid: 10323263
references.citation: Semin Cancer Biol. 2011 Apr;21(2):107-12
references.pmid: 21167939
references.citation: Mol Cancer. 2010 Jul 07;9:179
references.pmid: 20609236
references.citation: Nat Immunol. 2013 Oct;14(10):1014-22
references.pmid: 24048123
references.citation: Mol Cell Biol. 2011 Feb;31(4):710-20
references.pmid: 21173164
references.citation: Chin Clin Oncol. 2015 Jun;4(2):18
references.pmid: 26112804
references.citation: Proc Natl Acad Sci U S A. 1987 May;84(10):3249-53
references.pmid: 2953024
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: J Investig Dermatol Symp Proc. 1996 Apr;1(2):188-94
references.pmid: 9627715
references.citation: Invest Ophthalmol Vis Sci. 2007 Jan;48(1):368-75
references.pmid: 17197556
references.citation: Int J Cancer. 1995 Jan 17;60(2):221-9
references.pmid: 7829220
references.citation: Cancer Res. 1999 Feb 15;59(4):872-9
references.pmid: 10029078
references.citation: Clin Exp Immunol. 2015 Nov;182(2):162-72
references.pmid: 26212126
references.citation: Am J Pathol. 2000 Apr;156(4):1381-93
references.pmid: 10751362
references.citation: Acta Biochim Pol. 2004;51(2):445-57
references.pmid: 15218541
references.citation: J Cell Sci. 2011 Oct 1;124(Pt 19):3189-97
references.pmid: 21940791
references.citation: Pathobiology. 2013;80(5):245-51
references.pmid: 23635392
references.citation: In Vitro Cell Dev Biol Anim. 2000 Jun;36(6):387-94
references.pmid: 10949998
references.citation: Nat Med. 2003 Sep;9(9):1158-65
references.pmid: 12897778
references.citation: Histol Histopathol. 2004 Jul;19(3):973-83
references.pmid: 15168359
references.citation: Blood. 1983 Apr;61(4):676-83
references.pmid: 6831034
references.citation: J Interferon Res. 1990 Feb;10(1):91-7
references.pmid: 2158517
references.citation: Eur J Immunol. 2007 Dec;37(12):3334-8
references.pmid: 18034430
references.citation: Mol Cancer Res. 2011 Dec;9(12):1608-20
references.pmid: 21840933
references.citation: Acta Oncol. 2009;48(6):901-8
references.pmid: 19274498
references.citation: Lancet. 2014 Mar 1;383(9919):816-27
references.pmid: 24054424
references.citation: J Biomech. 2000 Jan;33(1):35-43
references.pmid: 10609516
references.citation: Cancer Invest. 1996;14(1):25-53
references.pmid: 8597888
references.citation: Clin Cardiol. 2001 Apr;24(4):286-90
references.pmid: 11303695
references.citation: Int J Mol Sci. 2013 Jan 15;14(1):1713-27
references.pmid: 23322021
references.citation: Am J Pathol. 2011 Jul;179(1):400-10
references.pmid: 21703419
references.citation: Biophys J. 2008 Feb 1;94(3):1046-51
references.pmid: 17921217
references.citation: J Control Release. 2015 Dec 28;220(Pt A):341-7
references.pmid: 26522070
references.citation: Wound Repair Regen. 2011 Sep-Oct;19(5):568-78
references.pmid: 22092795
references.citation: Nature. 2005 Jul 28;436(7050):518-24
references.pmid: 16049480
references.citation: J Cell Sci. 2013 Jan 15;126(Pt 2):393-401
references.pmid: 23525005
references.citation: Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006536
references.pmid: 22393533
references.citation: Annu Rev Biomed Eng. 2014 Jul 11;16:321-46
references.pmid: 25014786
references.citation: J Control Release. 2015 Dec 10;219:215-23
references.pmid: 26409123
references.citation: Blood. 2006 Mar 1;107(5):1761-7
references.pmid: 16269611
references.citation: J Physiol. 2005 Oct 15;568(Pt 2):357-69
references.pmid: 16051630
references.citation: Endothelium. 2003;10(6):299-307
references.pmid: 14741845
references.citation: Am J Pathol. 2009 Nov;175(5):2023-33
references.pmid: 19808647
references.citation: Cancer Res. 1980 Jul;40(7):2281-7
references.pmid: 7388794
references.citation: J Investig Dermatol Symp Proc. 2005 Nov;10(2):153-63
references.pmid: 16358819